Menu Close

Generic Fioricet Mayne Pharma – Pill Identification: MIA 110

Butal/APAP/Caf 50-325-40mg Tab Mayne Pharma Pill Identification: MIA 110
Butal/APAP/Caf 50-325-40mg Tab
Mayne Pharma
Pill Identification: MIA 110

 

Mayne Pharma is a pharmaceutical company that focuses on developing, manufacturing, and marketing generic and branded pharmaceutical products. With a global presence, Mayne Pharma serves markets primarily in the United States, Australia, and other regions.

Key Aspects of Mayne Pharma:

  1. Product Portfolio:
    • Generic Pharmaceuticals: Mayne Pharma offers a broad range of generic drugs across various therapeutic areas, including dermatology, cardiology, women’s health, and more.
    • Branded Pharmaceuticals: The company also markets branded medications, focusing on niche therapeutic segments where they can offer significant clinical benefits.
    • Specialty Products: They provide specialty pharmaceuticals, which often involve complex formulations or delivery systems.
  2. Research and Development (R&D):
    • Mayne Pharma invests heavily in R&D to develop new and improved pharmaceutical products. Their R&D efforts focus on both the development of new chemical entities and the enhancement of existing medications.
    • The company has facilities dedicated to formulation development, analytical testing, and clinical trials to support their pipeline of new products.
  3. Manufacturing Capabilities:
    • State-of-the-Art Facilities: Mayne Pharma operates advanced manufacturing facilities in the United States and Australia. These facilities are equipped to produce a wide variety of dosage forms, including tablets, capsules, injectables, and topical products.
    • Quality Assurance: The company adheres to stringent quality control standards to ensure that their products meet regulatory requirements and are safe for patient use.
  4. Market Presence:
    • United States: The US market is a significant focus for Mayne Pharma, where they distribute a large portion of their generic and branded products.
    • Australia and International Markets: While they have a strong presence in Australia, Mayne Pharma also markets their products in other international regions.
  5. Strategic Partnerships:
    • Mayne Pharma collaborates with other pharmaceutical companies and research institutions to enhance their product offerings and expand their market reach.
    • These partnerships often involve co-development, licensing, and distribution agreements.
  6. Compliance and Certifications:
    • The company complies with all relevant regulatory standards, including those set by the FDA in the United States and other international regulatory bodies.
    • Mayne Pharma holds various certifications that attest to their commitment to quality and safety.

Vision and Mission:

Mayne Pharma’s mission is to improve health outcomes for patients by providing high-quality, affordable pharmaceuticals. They aim to be a leading specialty pharmaceutical company through innovation, operational excellence, and strategic growth.

Contact Information:

For more details about Mayne Pharma, their products, services, or business inquiries, you can visit their official website or contact them directly:

  • Website: Mayne Pharma
  • Phone: +61 8 8209 2666 (Australia) | +1 800 272 5525 (USA)
  • Headquarters: 1538 Main North Road, Salisbury South, SA 5106, Australia

This overview provides a comprehensive look at Mayne Pharma, highlighting their product offerings, R&D efforts, manufacturing capabilities, market presence, and commitment to quality and innovation in the pharmaceutical industry.

4 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *